Not Medical Advice
This publication exists because the information vacuum around peptides is dangerous. Filling it responsibly requires saying clearly what we are and what we are not.
What This Site Is
Cult of Peptides is an editorial publication. We report on peptide compounds — their regulatory status, the available scientific literature, and the documented experiences of people who use them. We cite our sources. We distinguish between animal studies and human trials. We distinguish between community consensus and clinical evidence. When we do not know something, we say so.
The founder of this publication has personal experience with the compounds covered here. That experience informs the writing. It does not make the writing medical advice.
What This Site Is Not
Nothing published on Cult of Peptides constitutes medical advice. Nothing here is a diagnosis, a treatment recommendation, or a prescription. No article on this site should be used as the basis for a medical decision without the involvement of a qualified physician — ideally one who is familiar with the compounds being discussed.
The editor of this publication is not a physician. The contributors to this publication are not acting in a clinical capacity. The information presented here — including dosing protocols, cycle structures, stacking approaches, and reported effects — is drawn from publicly available sources: scientific literature, community forums, and first-person accounts. It is presented for informational purposes. It is not a protocol designed for you.
The Distinction That Matters
There is a meaningful difference between what a compound has been reported to do and what a compound will do for you. Individual response varies. Contraindications exist. Drug interactions exist. Pre-existing conditions change the calculus. A protocol that was appropriate for one person, documented publicly, is not automatically appropriate for you — and the fact that we describe it does not mean we are recommending it.
Peptides, including those that are now legally compoundable following the April 2026 HHS action, remain prescription medications in the United States. The legal pathway to access them runs through a licensed physician and a licensed compounding pharmacy. If you are considering any compound discussed on this site, that pathway exists for a reason.
Specific Populations
The compounds covered on this site have not been studied in pregnant or breastfeeding individuals. The evidence base for most peptides in individuals with active malignancy, significant cardiac disease, autoimmune conditions, or endocrine disorders is limited or absent. If you fall into any of these categories, the appropriate starting point is a conversation with your physician — not an article on the internet.
On the Evidence Base
We are transparent about the state of the science because the science deserves transparency. For most compounds discussed here, the human clinical evidence is limited. Dosing protocols in common use are extrapolated from animal studies. Community consensus is not the same as clinical proof. We report both, clearly labelled, because a reader who understands the difference is better equipped than one who does not.
When a study is cited, we identify the study type, the population, and the relevant limitations. When community data is cited, we identify it as such. The two are not interchangeable, and we will not write as though they are.
Liability
Cult of Peptides, its editor, contributors, and affiliated entities accept no liability for decisions made based on content published on this site. Use of this site constitutes acknowledgment that the content is informational, not clinical, and that any health-related decision carries risk that only you and your physician can properly evaluate.
If you have a question about whether a specific compound is appropriate for your situation, the answer to that question belongs in a physician’s office. We mean that seriously. The compounds covered here are not supplements. They are pharmacologically active molecules. Treat them accordingly.